Sharmila Shankar

University Of Texas Hlth Ctr At Tyler

$138,392

Attributed

$138,392

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $69.6K · FY2007–25

$100K$75K$50K$25K$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$138,392 · 1

VA$0 · 2

By mechanism

R03$138,392 · 1

I01$0 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Ctr At Tyler

Same institution · by research overlap

Rakesh K. Srivastava$4,102,428

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoCellsIn VitroChemotherapyTumorGrowthRadiation TherapyNovel StrategiesMolecularImplantMalignant NeoplasmsMediatingCancer InitiationNeoplasm MetastasisNotch ProteinBiologicalCancer Stem CellMouse ModelBaseMalignant Neoplasm Of PancreasPancreasPathway InteractionsPluripotencySelf-Renewal